Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Bryan Johnson: Psychedelics may revolutionize anti-aging, psilocybin enhances neuroplasticity for mental health, and the default mode network’s role in cognitive rejuvenation | All-In Podcast
Key Takeaways
Guest intro
Bryan Johnson is a centimillionaire tech entrepreneur and founder of Blueprint, a life-extension system where he applies data-driven health optimization to reduce his biological age. He previously founded Braintree, a payment-processing platform that acquired Venmo and was sold to PayPal for $800 million in 2013, and he established Kernel, a neurotechnology company developing brain-imaging technology to detect cognitive impairment. Johnson has spent over $4 million annually on experimental health interventions, including psychedelic research, positioning him as a prominent figure in the longevity and human optimization space.
The potential of psychedelics in anti-aging
Understanding the default mode network
Neuroplasticity and mental health
The effects of Five MEO DMT
Challenges in brain rejuvenation
Advancements in ketamine therapy
The potential of psychedelics in longevity
Risks associated with psychedelics
The risks associated with psychedelics often stem from unregulated use in social settings without proper knowledge of the substances involved. “People who have tried magic mushrooms… have no idea what kind of mushroom strain they’re eating… unquantified unsupervised wrong set in setting.” – Bryan Johnson
Understanding the risks of psychedelic use is crucial for developing safe and effective therapeutic approaches.
The exploration of psychedelic risks highlights the importance of regulation and education.
Insights into psychedelic risks provide valuable information for mitigating potential harm.
The risks of psychedelics underscore the need for proper knowledge and supervision in their use.
Understanding the risks associated with psychedelics is essential for advancing safe therapeutic applications.
The exploration of psychedelic risks contributes to the broader understanding of mental health treatments.
The potential risks of psychedelics highlight the importance of ongoing research and innovation.